The EGFRvIII variant in glioblastoma multiforme

This publication has 84 references indexed in Scilit:

• Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
  Seminars in Immunology, 2008
• Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma
  Proceedings of the National Academy of Sciences, 2007
• Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
  British Journal of Cancer, 2007
• A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
  Proceedings of the National Academy of Sciences, 2007
• A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII
  Molecular Cancer, 2007
• AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
  Cancer Cell, 2007
• Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
  Proceedings of the National Academy of Sciences, 2006
• NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994
  Neuro-Oncology, 1999
• Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line
  Biochemical and Biophysical Research Communications, 1985